Alyssa Harris, MS, Joins Pittsburgh-area-based Contract Research Organization, Clinical Research Strategies, LLC, as Clinical and Regulatory Affairs Project Lead
Pittsburgh, PA – February 1, 2021. Clinical Research Strategies, LLC (“CRS”), a Pittsburgh-area-based, US-owned and operated contract research organization (CRO) and executive management consultancy for the life sciences industry is pleased to announce the addition of Alyssa Harris, MS, Clinical and Regulatory Affairs Project Lead, to the firm. Ms. Harris earned her master’s degree from the University of Pittsburgh in Health, Physical Activity and Chronic Disease (research track) and joins the team as an experienced project lead in a federally funded research program in premature newborn critical care indications at UPMC Magee Women’s Hospital. Most recently, Ms. Harris helped lead 11 participating research sites in a large, multi-center, interventional randomized clinical trial involving the most vulnerable newborns with gestational age of 23-28 weeks.
Prior to UPMC Magee Women’s Hospital, Ms. Harris worked for the University of Pittsburgh’s Healthy Lifestyle Institute as a researcher and instructor involved with study protocols and other intervention sessions for adults in a variety of weight control and physical activity programs. Ms. Harris remains very active in teaching yoga, marathon running, and other recreational activities, and is a certified CPR instructor.
“Alyssa truly demonstrates the prerequisite energy, desire to learn and contribute, and character traits of empathy and trust that we look for in our colleagues,” says Alethea Wieland, president and co-founder. Wieland adds, “Without question, Alyssa will be a value-add to our consulting and clinical research practice groups, and we look forward to expanding her leadership skills in preparation to become among the next generation of life sciences leaders.”
About Clinical Research Strategies, LLC: CRS is a specialty CRO and executive management consulting firm that fits-for-purpose veteran life sciences executives, attorneys, regulatory scientists and strategists, clinical operations, project management, quality assurance engineers, and sales and marketing teams to take on the biggest challenges for start-up and mid-sized life sciences companies, many of whom are developing novel, first-in-class drugs, biologics, diagnostics and medical devices, or software as a medical device (SaMD). Service areas are clinical trials, Functional Service Provider (FSP) models, selection and management of CROs, regulatory compliance strategy and submissions, QMS, EU MDR and GDPR, rescue trials, TMF, risk mitigation and remediation, training high-performing teams, staffing solutions, and decentralized trials.
Indications represented are precision medicine, immuno-oncology, central nervous system, infectious diseases, respiratory diseases, orthopedics, de novo devices, digital health and mobile apps, reproductive health, regenerative medicine, cardiology, major depressive disorder, opioid-sparing pain, cannabis, radiology, and critical care. CRS is a qualified service provider for federal grants.
CRS is an inclusive employer and does not discriminate in employment on the basis of race, color, religion, sex, gender identity, national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, education, membership in an employee organization, parental status, military service, or other non-merit factor. CRS does not tolerate censorship, surveillance, bullying, intimidation, retaliation, discrimination, or harassment of any kind.
# # #
Step2 Branding & Design
Alethea Wieland, President and Founder
Clinical Research Strategies, LLC